Abstract
Summary
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
The global market for Olanzapine API was estimated to be worth US$ 193 million in 2023 and is forecast to a readjusted size of US$ 225.5 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Olanzapine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Olanzapine API by region & country, by Type, and by Application.
The Olanzapine API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine API.
Market Segmentation
By Company
Dr. Reddy's Laboratories
Inke
Solara Active Pharma
Teva API
Cadila Pharmaceuticals
Anant Labs
Lavybens Pharma
Jubilant Generics
Venkatasai Life Sciences
Hangzhou Longshine Bio-tech
Neuland Lab
Segment by Type:
Oral Grade
Injection Grade
Segment by Application
Olanzapine Tablets
Olanzapine Injection
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Olanzapine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Olanzapine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Olanzapine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Olanzapine API was estimated to be worth US$ 193 million in 2023 and is forecast to a readjusted size of US$ 225.5 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Olanzapine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Olanzapine API by region & country, by Type, and by Application.
The Olanzapine API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine API.
Market Segmentation
By Company
Dr. Reddy's Laboratories
Inke
Solara Active Pharma
Teva API
Cadila Pharmaceuticals
Anant Labs
Lavybens Pharma
Jubilant Generics
Venkatasai Life Sciences
Hangzhou Longshine Bio-tech
Neuland Lab
Segment by Type:
Oral Grade
Injection Grade
Segment by Application
Olanzapine Tablets
Olanzapine Injection
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Olanzapine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Olanzapine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Olanzapine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Olanzapine API Product Introduction
1.2 Global Olanzapine API Market Size Forecast
1.2.1 Global Olanzapine API Sales Value (2019-2030)
1.2.2 Global Olanzapine API Sales Volume (2019-2030)
1.2.3 Global Olanzapine API Sales Price (2019-2030)
1.3 Olanzapine API Market Trends & Drivers
1.3.1 Olanzapine API Industry Trends
1.3.2 Olanzapine API Market Drivers & Opportunity
1.3.3 Olanzapine API Market Challenges
1.3.4 Olanzapine API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Olanzapine API Players Revenue Ranking (2023)
2.2 Global Olanzapine API Revenue by Company (2019-2024)
2.3 Global Olanzapine API Players Sales Volume Ranking (2023)
2.4 Global Olanzapine API Sales Volume by Company Players (2019-2024)
2.5 Global Olanzapine API Average Price by Company (2019-2024)
2.6 Key Manufacturers Olanzapine API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Olanzapine API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Olanzapine API
2.9 Olanzapine API Market Competitive Analysis
2.9.1 Olanzapine API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Olanzapine API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olanzapine API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Grade
3.1.2 Injection Grade
3.2 Global Olanzapine API Sales Value by Type
3.2.1 Global Olanzapine API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Olanzapine API Sales Value, by Type (2019-2030)
3.2.3 Global Olanzapine API Sales Value, by Type (%) (2019-2030)
3.3 Global Olanzapine API Sales Volume by Type
3.3.1 Global Olanzapine API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Olanzapine API Sales Volume, by Type (2019-2030)
3.3.3 Global Olanzapine API Sales Volume, by Type (%) (2019-2030)
3.4 Global Olanzapine API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Olanzapine Tablets
4.1.2 Olanzapine Injection
4.2 Global Olanzapine API Sales Value by Application
4.2.1 Global Olanzapine API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Olanzapine API Sales Value, by Application (2019-2030)
4.2.3 Global Olanzapine API Sales Value, by Application (%) (2019-2030)
4.3 Global Olanzapine API Sales Volume by Application
4.3.1 Global Olanzapine API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Olanzapine API Sales Volume, by Application (2019-2030)
4.3.3 Global Olanzapine API Sales Volume, by Application (%) (2019-2030)
4.4 Global Olanzapine API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Olanzapine API Sales Value by Region
5.1.1 Global Olanzapine API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Olanzapine API Sales Value by Region (2019-2024)
5.1.3 Global Olanzapine API Sales Value by Region (2025-2030)
5.1.4 Global Olanzapine API Sales Value by Region (%), (2019-2030)
5.2 Global Olanzapine API Sales Volume by Region
5.2.1 Global Olanzapine API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Olanzapine API Sales Volume by Region (2019-2024)
5.2.3 Global Olanzapine API Sales Volume by Region (2025-2030)
5.2.4 Global Olanzapine API Sales Volume by Region (%), (2019-2030)
5.3 Global Olanzapine API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Olanzapine API Sales Value, 2019-2030
5.4.2 North America Olanzapine API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Olanzapine API Sales Value, 2019-2030
5.5.2 Europe Olanzapine API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Olanzapine API Sales Value, 2019-2030
5.6.2 Asia Pacific Olanzapine API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Olanzapine API Sales Value, 2019-2030
5.7.2 South America Olanzapine API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Olanzapine API Sales Value, 2019-2030
5.8.2 Middle East & Africa Olanzapine API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Olanzapine API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Olanzapine API Sales Value
6.2.1 Key Countries/Regions Olanzapine API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Olanzapine API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Olanzapine API Sales Value, 2019-2030
6.3.2 United States Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Olanzapine API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Olanzapine API Sales Value, 2019-2030
6.4.2 Europe Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Olanzapine API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Olanzapine API Sales Value, 2019-2030
6.5.2 China Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Olanzapine API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Olanzapine API Sales Value, 2019-2030
6.6.2 Japan Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Olanzapine API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Olanzapine API Sales Value, 2019-2030
6.7.2 South Korea Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Olanzapine API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Olanzapine API Sales Value, 2019-2030
6.8.2 Southeast Asia Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Olanzapine API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Olanzapine API Sales Value, 2019-2030
6.9.2 India Olanzapine API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Olanzapine API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Company Information
7.1.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.1.3 Dr. Reddy's Laboratories Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Dr. Reddy's Laboratories Olanzapine API Product Offerings
7.1.5 Dr. Reddy's Laboratories Recent Development
7.2 Inke
7.2.1 Inke Company Information
7.2.2 Inke Introduction and Business Overview
7.2.3 Inke Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Inke Olanzapine API Product Offerings
7.2.5 Inke Recent Development
7.3 Solara Active Pharma
7.3.1 Solara Active Pharma Company Information
7.3.2 Solara Active Pharma Introduction and Business Overview
7.3.3 Solara Active Pharma Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Solara Active Pharma Olanzapine API Product Offerings
7.3.5 Solara Active Pharma Recent Development
7.4 Teva API
7.4.1 Teva API Company Information
7.4.2 Teva API Introduction and Business Overview
7.4.3 Teva API Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Teva API Olanzapine API Product Offerings
7.4.5 Teva API Recent Development
7.5 Cadila Pharmaceuticals
7.5.1 Cadila Pharmaceuticals Company Information
7.5.2 Cadila Pharmaceuticals Introduction and Business Overview
7.5.3 Cadila Pharmaceuticals Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cadila Pharmaceuticals Olanzapine API Product Offerings
7.5.5 Cadila Pharmaceuticals Recent Development
7.6 Anant Labs
7.6.1 Anant Labs Company Information
7.6.2 Anant Labs Introduction and Business Overview
7.6.3 Anant Labs Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Anant Labs Olanzapine API Product Offerings
7.6.5 Anant Labs Recent Development
7.7 Lavybens Pharma
7.7.1 Lavybens Pharma Company Information
7.7.2 Lavybens Pharma Introduction and Business Overview
7.7.3 Lavybens Pharma Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lavybens Pharma Olanzapine API Product Offerings
7.7.5 Lavybens Pharma Recent Development
7.8 Jubilant Generics
7.8.1 Jubilant Generics Company Information
7.8.2 Jubilant Generics Introduction and Business Overview
7.8.3 Jubilant Generics Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jubilant Generics Olanzapine API Product Offerings
7.8.5 Jubilant Generics Recent Development
7.9 Venkatasai Life Sciences
7.9.1 Venkatasai Life Sciences Company Information
7.9.2 Venkatasai Life Sciences Introduction and Business Overview
7.9.3 Venkatasai Life Sciences Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Venkatasai Life Sciences Olanzapine API Product Offerings
7.9.5 Venkatasai Life Sciences Recent Development
7.10 Hangzhou Longshine Bio-tech
7.10.1 Hangzhou Longshine Bio-tech Company Information
7.10.2 Hangzhou Longshine Bio-tech Introduction and Business Overview
7.10.3 Hangzhou Longshine Bio-tech Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Hangzhou Longshine Bio-tech Olanzapine API Product Offerings
7.10.5 Hangzhou Longshine Bio-tech Recent Development
7.11 Neuland Lab
7.11.1 Neuland Lab Company Information
7.11.2 Neuland Lab Introduction and Business Overview
7.11.3 Neuland Lab Olanzapine API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Neuland Lab Olanzapine API Product Offerings
7.11.5 Neuland Lab Recent Development
8 Industry Chain Analysis
8.1 Olanzapine API Industrial Chain
8.2 Olanzapine API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Olanzapine API Sales Model
8.5.2 Sales Channel
8.5.3 Olanzapine API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer